bioRxivImmunology
Relative positioning of B and T cell epitopes drives immunodominance.
Abstract
Humoral immunity is crucial for protection against invading pathogens. Broadly neutralizing antibodies (bnAbs) provide sterilizing immunity by targeting conserved regions of viral variants and represent the goal of most vaccination approaches. While antibodies can be selected to bind virtually any region of a given antigen, consistent induction of bnAbs in the context of influenza and HIV has been representing a major roadblock. Many possible explanations have been considered, however, none of the arguments proposed so far seems to fully recapitulate the observed counter-selection for broadly protective antibodies. Antibodies can influence antigen presentation by enhancing the processing of CD4 epitopes adjacent to the binding region while suppressing the overlapping ones. We analyzed the relative positioning of dominant B and T cell epitopes in published antigens that elicit strong and poor humoral responses. In strong immunogenic antigens, regions bound by immunodominant antibodies are frequently adjacent to CD4 epitopes, potentially boosting their presentation. Conversely, poorly immunogenic regions targeted by bnAbs in HIV and influenza overlap with clusters of dominant CD4 epitopes, potentially conferring an intrinsic disadvantage for bnAb-bearing B cells in germinal centers. Here we propose the theory of immunodominance relativity, according to which relative positioning of immunodominant B and CD4 epitopes within a given antigen drives immunodominance. Thus, we suggest that relative positioning of B-T epitopes may be one additional mechanism that cooperates with other previously described processes to influence immunodominance. If demonstrated, this theory can improve the current understanding of immunodominance, provide a novel explanation on HIV and influenza escape from humoral responses, and pave the way for new rational design of universal vaccines.
- research focus: host-pathogen & immune response
- research focus: drug response / drug discovery
- research focus: variant calling
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Immunodominance is a poor predictor of vaccine-induced T follicular helper cell quality
Hyon‐Xhi Tan, MZM Zheng, … Jennifer A. Juno·bioRxiv·Jul 21, 2025
- Outflanking Immunodominance to Target Subdominant Broadly Neutralizing Epitopes
D. Angeletti, I. Kosik, … J. W. Yewdell·bioRxiv·Jun 14, 2018
- Injection of antibodies against immunodominant epitopes tunes germinal centres to generate broadly neutralizing antibodies
M. Meyer-Hermann·bioRxiv·Dec 19, 2018
- Germinal centers are permissive to subdominant antibody responses
Philippe Auguste Robert, Theinmozhi Arulraj, Michael Meyer‐Hermann·Frontiers in ImmunologyPeer-reviewed·Jan 10, 2024
- An epitope-enriched immunogen increases site targeting in germinal centers
T. M. Caradonna, I. W. Windsor, … A. G. Schmidt·bioRxiv·Dec 1, 2022
- Anti-Immune Complex Antibodies are Elicited During Repeated Immunization with HIV Env Immunogens
Sharidan Brown, Aleksandar Antanasijevic, … Andrew B. Ward·Science ImmunologyPeer-reviewed·Jan 17, 2025